Skip to main content
Markets · Live
DJIA50,687.07▼ -1.21%S&P 5007,553.68▼ -0.74%Nasdaq26,853.98▼ -0.89%Nvidia—▼ TSMC—▼ Alphabet—▼ Bitcoin—▼ DJIA50,687.07▼ -1.21%S&P 5007,553.68▼ -0.74%Nasdaq26,853.98▼ -0.89%Nvidia—▼ TSMC—▼ Alphabet—▼ Bitcoin—▼
New York--:--
Chicago--:--
Denver--:--
Los Angeles--:--
Honolulu--:--
Anchorage--:--
Tokyo--:--
Berlin--:--
London--:--
UTC--:--

Breaking

BLOOMBERG MARKETS — Dimon Concerned Inflation May Be Sticky, Rates Go Up · Oct 6, 10:07 AM ET
STAT

STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more

The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing deals for Chinese drugs

Ed Silverman
By Ed Silverman· STAT News· Published · Photo: Alex Hogan/STAT

Rights: fair use excerpt

STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more
Reporting by Ed SilvermanSource: STAT NewsPhoto: Alex Hogan/STATUpdated October 6, 2026
PHOTO: ALEX HOGAN/STAT

---

Ed Silverman · STAT News · Photo: Alex Hogan/STAT

Source & Credit

Reporting and photography credited as noted above. Originally published by STAT News.

Members only

Checking your membership…